Sentence examples for between screening and control from inspiring English sources

Misclassifications due to a reviewer's beliefs about screening are unlikely to be differential if those participants the reviewer thinks are in a particular trial arm are actually equally split between screening and control arms.

Two diabetes screening studies reported no difference in self-rated health between screening and control groups in a trial at 12 15 months [ 12] or between those who screened negative and unscreened individuals at 3 6 months or 12 15 months after screening [ 13].

More recently, two diabetes screening studies reported no difference in self-rated health between the screening and control groups in a trial at 12 15 months [ 12] or between those who screened negative and unscreened individuals at 3 6 months or 12 15 months after screening [ 13].

These include the choice of the appropriate screening threshold and interval, the issue of contamination between the screening and control arm, and compliance with recommendations for biopsy.

Results No difference was found in the 7 year cumulative incidence of colorectal cancer between the screening and control groups (134.5 v 131.9 cases per 100 000 person years).

Hence the misclassifications due to beliefs about screening are non-differential between the actual screening and control arms.

The aim of this observational study was to describe and evaluate the association between MRSA incidence densities (IDs) and screening and control measures in ICUs participating in the German Nosocomial Infection Surveillance System.

What it had was devastatingly slow apps with long load times between screens and unresponsive controls.

In particular, the rs3771829 allele frequency was significantly different between screened and unscreened controls (P = 0.003, OR 1.67, CI 1.19 2.36).

MRSA IDs as well as implemented MRSA screening and control measures varied widely between ICUs.

A discussion of commonly employed data analyses comes next, and includes methods for the primary analysis (comparison of cause-specific mortality rates between the screened and control arms for the cancer of interest), as well as for secondary endpoints such as sensitivity.